Breaking the PCR-Only Barrier: Dual 510(k) Clearance and CLIA-Waiver Establish FINDER as the First Molecular Point-of-Care Platform with Multifunctional Capabilities

Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER® Flu A&B/SARS-CoV-2 Test, an ultra-rapid ...
PharmiWeb

Molecular Infectious Disease Testing Market: Growth, Innovations, and Opportunities

Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Medscape

Enhancing Molecular Approaches for Diagnosis of Fungal Infections

The fraction, volume and frequency of the patient sample collection; DNA extraction and purification procedures, which greatly influence the performance of the downstream molecular tests. It is worth ...
The American Journal of Managed Care

Combined Diagnostic Approach Improves Accuracy in Differentiating Eczema From Psoriasis

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...
Becker's Hospital Review

Closing the Rural Diagnostic Gap with Next-Morning PCR Tests for Infections

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...